GlassScriptPhysician profile
Ashley D Peace
NPI 1043622558
$27,264.65
in general payments reported to CMS, 2019-2025
34 companies · $16K in 2025
The $16K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $217 · 2022: $1,457 · 2023: $1,003 · 2024: $8,743 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $6,402 · Travel and Lodging: $2,075 · Education: $84.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,030.00 |
| Food and Beverage | $6,401.57 |
| Travel and Lodging | $2,075.41 |
| Education | $84.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $12,024.96 | 2024-2025 | Rezdiffra, Resmetirom |
| Gilead Sciences, INC. | $9,461.26 | 2021-2025 | Epclusa, Veklury |
| Abbvie INC. | $2,531.59 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $601.34 | 2021-2025 | Entyvio, Gattex, Livtencity |
| Janssen Biotech, INC. | $463.26 | 2022-2025 | Tremfya, Stelara |
| Ipsen Biopharmaceuticals, INC | $250.78 | 2024-2025 | Iqirvo |
| Ardelyx, INC. | $225.09 | 2023-2025 | Ibsrela |
| Pfizer INC. | $223.23 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $215.00 | 2023-2025 | Dupixent |
| Phathom Pharmaceuticals, INC. | $172.18 | 2024-2025 | Voquezna |
| Lilly USA, LLC | $156.69 | 2024-2025 | Omvoh |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $145.63 | 2021-2025 | Xifaxan, Trulance, Relistor |
| Intercept Pharmaceuticals, INC. | $113.73 | 2022-2025 | Ocaliva |
| Genzyme Corporation | $83.89 | 2022-2025 | |
| Novo Nordisk INC | $81.97 | 2025 | Wegovy |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $76.85 | 2022-2025 | Injectafer |
| Mallinckrodt Hospital Products INC. | $60.86 | 2022 | |
| Merck Sharp & Dohme LLC | $55.00 | 2022-2024 | Dificid |
| Exact Sciences Corporation | $38.61 | 2024-2025 | Cologuard Collection Kit |
| Ironwood Pharmaceuticals, INC | $38.42 | 2022 | |
| Redhill Biopharma INC. | $26.02 | 2022 | |
| Hikma Pharmaceuticals USA | $25.68 | 2022 | |
| Qol Medical, LLC | $22.89 | 2024 | Sucraid |
| Pharmacosmos Therapeutics INC. | $19.92 | 2022 | |
| Evoke Pharma, INC. | $17.51 | 2024 | |
| Vbi Vaccine (Delaware) INC. | $17.15 | 2022 | |
| Fresenius Kabi USA, LLC | $16.32 | 2023 | Idacio |
| Alnylam Pharmaceuticals INC. | $16.11 | 2025 | Givlaari |
| Celltrion USA INC. | $14.93 | 2024 | Vegzelma |
| Ferring Pharmaceuticals INC. | $14.68 | 2023 | Cimzia |
| Aimmune Therapeutics, INC. | $13.81 | 2025 | Zenpep |
| Organon LLC | $13.59 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.16 | 2024 | Cyltezo |
| Impel Pharmaceuticals INC. | $12.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Peace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.